Review



anti human cd161  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Proteintech anti human cd161
    Anti Human Cd161, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human cd161/product/Proteintech
    Average 94 stars, based on 1 article reviews
    anti human cd161 - by Bioz Stars, 2026-05
    94/100 stars

    Images



    Similar Products

    96
    Miltenyi Biotec anti cd161 pevio770
    Anti Cd161 Pevio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd161 pevio770/product/Miltenyi Biotec
    Average 96 stars, based on 1 article reviews
    anti cd161 pevio770 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    94
    MedChemExpress kras wt cclp1 human btc cell lines
    Kras Wt Cclp1 Human Btc Cell Lines, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kras wt cclp1 human btc cell lines/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    kras wt cclp1 human btc cell lines - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    94
    Novus Biologicals nk1 1
    Nk1 1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nk1 1/product/Novus Biologicals
    Average 94 stars, based on 1 article reviews
    nk1 1 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology pe anti mouse cd161 nk1 1 antibody
    Pe Anti Mouse Cd161 Nk1 1 Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe anti mouse cd161 nk1 1 antibody/product/Elabscience Biotechnology
    Average 94 stars, based on 1 article reviews
    pe anti mouse cd161 nk1 1 antibody - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    94
    Proteintech anti human cd161
    Anti Human Cd161, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human cd161/product/Proteintech
    Average 94 stars, based on 1 article reviews
    anti human cd161 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec pe klrb1 cd161
    Pe Klrb1 Cd161, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe klrb1 cd161/product/Miltenyi Biotec
    Average 93 stars, based on 1 article reviews
    pe klrb1 cd161 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Proteintech cd161
    (A–C) Positive and negative controls of tonsillar tissue. (A) LLT1 expression showing membranous/cytoplasmic staining in lymphoid cells within tonsillar follicles. (B) <t>CD161</t> expression highlighting scattered lymphocytes in the interfollicular areas. (C) Negative control by omission of the primary antibody showed complete absence of staining (IHC stain, 20x).
    Cd161, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd161/product/Proteintech
    Average 93 stars, based on 1 article reviews
    cd161 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology anti cd161 nk1 1 antibody
    (A–C) Positive and negative controls of tonsillar tissue. (A) LLT1 expression showing membranous/cytoplasmic staining in lymphoid cells within tonsillar follicles. (B) <t>CD161</t> expression highlighting scattered lymphocytes in the interfollicular areas. (C) Negative control by omission of the primary antibody showed complete absence of staining (IHC stain, 20x).
    Anti Cd161 Nk1 1 Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd161 nk1 1 antibody/product/Elabscience Biotechnology
    Average 94 stars, based on 1 article reviews
    anti cd161 nk1 1 antibody - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology anti cd161 nk1 1
    (A–C) Positive and negative controls of tonsillar tissue. (A) LLT1 expression showing membranous/cytoplasmic staining in lymphoid cells within tonsillar follicles. (B) <t>CD161</t> expression highlighting scattered lymphocytes in the interfollicular areas. (C) Negative control by omission of the primary antibody showed complete absence of staining (IHC stain, 20x).
    Anti Cd161 Nk1 1, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd161 nk1 1/product/Elabscience Biotechnology
    Average 94 stars, based on 1 article reviews
    anti cd161 nk1 1 - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A–C) Positive and negative controls of tonsillar tissue. (A) LLT1 expression showing membranous/cytoplasmic staining in lymphoid cells within tonsillar follicles. (B) CD161 expression highlighting scattered lymphocytes in the interfollicular areas. (C) Negative control by omission of the primary antibody showed complete absence of staining (IHC stain, 20x).

    Journal: Frontiers in Medicine

    Article Title: Reed-Sternberg cells express CD161 and lectin-like transcript 1 in Hodgkin lymphoma

    doi: 10.3389/fmed.2026.1754727

    Figure Lengend Snippet: (A–C) Positive and negative controls of tonsillar tissue. (A) LLT1 expression showing membranous/cytoplasmic staining in lymphoid cells within tonsillar follicles. (B) CD161 expression highlighting scattered lymphocytes in the interfollicular areas. (C) Negative control by omission of the primary antibody showed complete absence of staining (IHC stain, 20x).

    Article Snippet: The sections were incubated with primary antibodies specific to CD161 (anti-KLRB1/CD161 mAb clone 3D8F5, Proteintech Catalog No. 67537-1-Ig, RRID: AB_2882756 , 1:1,000), LLT1 (anti-CLEC2D mAb clone 4C7, Abnova, Catalog No. H00029121-M01, RRID: AB_463941 , 1:50), CD8 (anti-CD8 mAb clone 4B11, MyBioSource Catalog No. MBS215242, RRID: AB_10887243 , 1:50), and EBV (anti-EBV/LMP-1 mAb clone S20-D, MyBioSource Catalog No. MBS684063, 1:100).

    Techniques: Expressing, Staining, Negative Control

    (A–F) . CD161 expression patterns in Reed–Sternberg RS cells by immunohistochemistry (40x and 100x inset). (A) No detectable CD161 expression in RS cells, background immune cells are positive. (B) Low-level cytoplasmic only expression. (C) High-level cytoplasmic only expression. (D) High-level membranous-only expression. (E) Low-level dual cytoplasmic and membranous expression. (F) High-level dual cytoplasmic and membranous expression. The total expression level was calculated by multiplying the stain intensity score by the percentage of positive RS cells. Based on the median score, patients were classified into low expression (≤90; median), and high expression (>90; median) groups.

    Journal: Frontiers in Medicine

    Article Title: Reed-Sternberg cells express CD161 and lectin-like transcript 1 in Hodgkin lymphoma

    doi: 10.3389/fmed.2026.1754727

    Figure Lengend Snippet: (A–F) . CD161 expression patterns in Reed–Sternberg RS cells by immunohistochemistry (40x and 100x inset). (A) No detectable CD161 expression in RS cells, background immune cells are positive. (B) Low-level cytoplasmic only expression. (C) High-level cytoplasmic only expression. (D) High-level membranous-only expression. (E) Low-level dual cytoplasmic and membranous expression. (F) High-level dual cytoplasmic and membranous expression. The total expression level was calculated by multiplying the stain intensity score by the percentage of positive RS cells. Based on the median score, patients were classified into low expression (≤90; median), and high expression (>90; median) groups.

    Article Snippet: The sections were incubated with primary antibodies specific to CD161 (anti-KLRB1/CD161 mAb clone 3D8F5, Proteintech Catalog No. 67537-1-Ig, RRID: AB_2882756 , 1:1,000), LLT1 (anti-CLEC2D mAb clone 4C7, Abnova, Catalog No. H00029121-M01, RRID: AB_463941 , 1:50), CD8 (anti-CD8 mAb clone 4B11, MyBioSource Catalog No. MBS215242, RRID: AB_10887243 , 1:50), and EBV (anti-EBV/LMP-1 mAb clone S20-D, MyBioSource Catalog No. MBS684063, 1:100).

    Techniques: Expressing, Immunohistochemistry, Staining

    Overall survival (OS) according to CD161 expression in RS cells. Kaplan-Meier curves OS stratified by LLT1 expression in RS cells based on immunohistochemistry score median. Patients were grouped into low LLT1 expression (≤90) and high LLT1 expression (>90). Tick marks indicate censored (alive/lost) cases. No statistically significant difference in overall survival was observed among groups with different CD161 expression levels in RS cells ( p -value = 0.277).

    Journal: Frontiers in Medicine

    Article Title: Reed-Sternberg cells express CD161 and lectin-like transcript 1 in Hodgkin lymphoma

    doi: 10.3389/fmed.2026.1754727

    Figure Lengend Snippet: Overall survival (OS) according to CD161 expression in RS cells. Kaplan-Meier curves OS stratified by LLT1 expression in RS cells based on immunohistochemistry score median. Patients were grouped into low LLT1 expression (≤90) and high LLT1 expression (>90). Tick marks indicate censored (alive/lost) cases. No statistically significant difference in overall survival was observed among groups with different CD161 expression levels in RS cells ( p -value = 0.277).

    Article Snippet: The sections were incubated with primary antibodies specific to CD161 (anti-KLRB1/CD161 mAb clone 3D8F5, Proteintech Catalog No. 67537-1-Ig, RRID: AB_2882756 , 1:1,000), LLT1 (anti-CLEC2D mAb clone 4C7, Abnova, Catalog No. H00029121-M01, RRID: AB_463941 , 1:50), CD8 (anti-CD8 mAb clone 4B11, MyBioSource Catalog No. MBS215242, RRID: AB_10887243 , 1:50), and EBV (anti-EBV/LMP-1 mAb clone S20-D, MyBioSource Catalog No. MBS684063, 1:100).

    Techniques: Expressing, Immunohistochemistry

    Progression-free survival (PFS) according to CD161 expression in RS cells. Kaplan–Meier curves showing progression-free survival (PFS) stratified by LLT1 expression in Reed–Sternberg (RS) cells based on the median immunohistochemistry (IHC) score. Patients were categorized into low LLT1 expression (≤90) and high LLT1 expression (>90). Tick marks indicate censored (alive/lost) cases. No statistically significant difference in progression-free survival between patients with low and high LLT1 expression on RS cells ( p = 0.734).

    Journal: Frontiers in Medicine

    Article Title: Reed-Sternberg cells express CD161 and lectin-like transcript 1 in Hodgkin lymphoma

    doi: 10.3389/fmed.2026.1754727

    Figure Lengend Snippet: Progression-free survival (PFS) according to CD161 expression in RS cells. Kaplan–Meier curves showing progression-free survival (PFS) stratified by LLT1 expression in Reed–Sternberg (RS) cells based on the median immunohistochemistry (IHC) score. Patients were categorized into low LLT1 expression (≤90) and high LLT1 expression (>90). Tick marks indicate censored (alive/lost) cases. No statistically significant difference in progression-free survival between patients with low and high LLT1 expression on RS cells ( p = 0.734).

    Article Snippet: The sections were incubated with primary antibodies specific to CD161 (anti-KLRB1/CD161 mAb clone 3D8F5, Proteintech Catalog No. 67537-1-Ig, RRID: AB_2882756 , 1:1,000), LLT1 (anti-CLEC2D mAb clone 4C7, Abnova, Catalog No. H00029121-M01, RRID: AB_463941 , 1:50), CD8 (anti-CD8 mAb clone 4B11, MyBioSource Catalog No. MBS215242, RRID: AB_10887243 , 1:50), and EBV (anti-EBV/LMP-1 mAb clone S20-D, MyBioSource Catalog No. MBS684063, 1:100).

    Techniques: Expressing, Immunohistochemistry